ABRAXANE

Brand name authorized in: Austria Australia Brazil Canada Cyprus Spain Finland France Hong Kong Ireland Lithuania Netherlands Poland Singapore United Kingdom United States

Active ingredients

The drug ABRAXANE contains one active pharmaceutical ingredient (API):

1 Paclitaxel albumin
UNII P88XT4IS4D - PACLITAXEL

Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability results in the inhibition of the normal dynamic reorganisation of the microtubule network that is essential for vital interphase and mitotic cellular functions.

Read about Paclitaxel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Paclitaxel
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD01

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of product characteristics (SPC)

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 10150F, 10165B, 4531L, 7270P
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 562417080000007
CA
Health Products and Food Branch
Identifier(s): 02281066
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 07428001
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 397641
FR
Base de données publique des médicaments
Identifier(s): 68739019
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 201590
HK
Department of Health Drug Office
Identifier(s): 62459
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1032063, 1072784
NL
Z-Index G-Standaard
Identifier(s): 15690172
NL
Z-Index G-Standaard, PRK
Identifier(s): 98957
PL
Rejestru Produktów Leczniczych
Identifier(s): 100265356
SG
Health Sciences Authority
Identifier(s): 14532P
US
FDA, National Drug Code
Identifier(s): 68817-134